All Work

Chris Lange

Is This DMD Study Sunk After FDA Update?

Solid Bio shares were absolutely crushed on Tuesday after the firm announced that the FDA has placed its Ignite DMD Phase 1/2 study of SGT-001 on hold.

Chris Lange · 7 years ago

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange · 7 years ago

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.

Chris Lange · 7 years ago

Is This FDA Update the Death of Lipocine?

Lipocine shares absolutely plummeted on Monday after the firm announced that it received a Complete Response Letter from the FDA regarding its New Drug Application for Tlando.

Chris Lange · 7 years ago

SunPower Poised to Split Into 2 Companies

SunPower shares shot up on Monday after the company announced that it plans to separate into two independent, complementary, strategically aligned and publicly traded companies: SunPower and Maxeon Solar Technologies.

Chris Lange · 7 years ago

Why Disney Is Crushing Q4 Earnings

Disney released fiscal fourth-quarter financial results after markets closed Tuesday. The Mouse House said that it had $1.07 in earnings per share (EPS) and $19.1 billion in revenue, compared with consensus estimates that called…

Chris Lange · 7 years ago

Can Yelp Make a Comeback With Q3 Earnings?

Yelp is set to report its most recent quarterly results after the closing bell on Thursday. Analysts are looking for year-on-year growth on the top and bottom lines.

Chris Lange · 7 years ago